Express Scripts Holding Co (ESRX) Stake Lowered by Meritage Portfolio Management

Meritage Portfolio Management lowered its position in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 0.5% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 102,255 shares of the company’s stock after selling 533 shares during the quarter. Express Scripts makes up about 0.9% of Meritage Portfolio Management’s investment portfolio, making the stock its 19th largest position. Meritage Portfolio Management’s holdings in Express Scripts were worth $9,715,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Abrams Capital Management L.P. bought a new stake in Express Scripts in the second quarter valued at approximately $204,846,000. Canada Pension Plan Investment Board raised its stake in Express Scripts by 124.5% in the second quarter. Canada Pension Plan Investment Board now owns 1,971,200 shares of the company’s stock valued at $152,196,000 after buying an additional 1,093,200 shares during the period. FMR LLC raised its stake in Express Scripts by 117.6% in the second quarter. FMR LLC now owns 1,419,840 shares of the company’s stock valued at $109,626,000 after buying an additional 767,426 shares during the period. Bank of Montreal Can bought a new stake in Express Scripts in the second quarter valued at approximately $54,695,000. Finally, BlackRock Inc. grew its position in shares of Express Scripts by 1.5% in the second quarter. BlackRock Inc. now owns 35,424,185 shares of the company’s stock valued at $2,735,103,000 after purchasing an additional 538,578 shares during the last quarter. 83.15% of the stock is owned by hedge funds and other institutional investors.

In other Express Scripts news, Director Mahon Thomas P. Mac sold 5,234 shares of Express Scripts stock in a transaction that occurred on Wednesday, November 7th. The shares were sold at an average price of $99.50, for a total transaction of $520,783.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.79% of the stock is owned by company insiders.

Shares of ESRX traded up $0.04 during trading hours on Thursday, hitting $95.33. The stock had a trading volume of 6,370,598 shares, compared to its average volume of 3,857,956. The company has a market cap of $53.73 billion, a PE ratio of 13.43, a P/E/G ratio of 1.20 and a beta of 0.89. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.77 and a quick ratio of 0.65. Express Scripts Holding Co has a 1-year low of $60.63 and a 1-year high of $100.43.

Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.42 by $0.01. Express Scripts had a return on equity of 25.43% and a net margin of 4.83%. The business had revenue of $25.56 billion during the quarter, compared to the consensus estimate of $25.11 billion. During the same quarter in the previous year, the business earned $2.51 EPS. The company’s quarterly revenue was up 3.6% on a year-over-year basis. Analysts expect that Express Scripts Holding Co will post 9.08 EPS for the current fiscal year.

ESRX has been the topic of several research reports. BidaskClub raised Express Scripts from a “hold” rating to a “buy” rating in a research report on Tuesday, September 18th. ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a research report on Monday, September 17th. Credit Suisse Group downgraded Express Scripts from an “outperform” rating to a “neutral” rating and increased their price target for the stock from $90.00 to $96.50 in a research report on Tuesday, September 18th. Royal Bank of Canada increased their price target on Express Scripts to $94.00 and gave the stock an “outperform” rating in a research report on Monday, August 27th. Finally, Mizuho set a $101.00 price target on Express Scripts and gave the stock a “hold” rating in a research report on Monday, November 5th. One investment analyst has rated the stock with a sell rating, thirteen have assigned a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $90.73.

COPYRIGHT VIOLATION WARNING: This article was posted by Enterprise Leader and is the property of of Enterprise Leader. If you are reading this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright law. The original version of this article can be viewed at https://theenterpriseleader.com/2018/11/22/meritage-portfolio-management-has-9-72-million-stake-in-express-scripts-holding-co-esrx.html.

Express Scripts Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Featured Article: Stock Symbol

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply